Tolazoline

CAS No. 59-98-3

Tolazoline ( Vasimid; Benzalolin; Divascol; Pridazole; Priscol; Priscoline )

Catalog No. M27407 CAS No. 59-98-3

Tolazoline, a non-selective competitive α-adrenergic receptor antagonist, is used as a vasodilator to treat spasms of peripheral blood vessels.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 45 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Tolazoline
  • Note
    Research use only, not for human use.
  • Brief Description
    Tolazoline, a non-selective competitive α-adrenergic receptor antagonist, is used as a vasodilator to treat spasms of peripheral blood vessels.
  • Description
    Tolazoline, a non-selective competitive α-adrenergic receptor antagonist, is used as a vasodilator to treat spasms of peripheral blood vessels. It has also been used successfully as an antidote to reverse the severe peripheral vasoconstriction as a result of overdose with certain 5-HT2A agonist drugs.
  • Synonyms
    Vasimid; Benzalolin; Divascol; Pridazole; Priscol; Priscoline
  • Pathway
    Angiogenesis
  • Target
    Adrenergic Receptor
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    59-98-3
  • Formula Weight
    160.2
  • Molecular Formula
    C10H12N2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C1=NCCN1)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Shotton DM, et, al. Amino-acid sequence of porcine pancreatic elastase and its homologies with other serine proteinases. Nature. 1970 Feb 28;225(5235):802-6.
molnova catalog
related products
  • Diosgenin glucoside

    Diosgenin glucoside and other synthetic glycosides with similar activities may be of use in the management of hypercholesterolemia and atherosclerosis.

  • Dabuzalgron

    Dabuzalgron is an orally active selective alpha-1A adrenergic receptor agonist used to treat urinary incontinence. Dabuzaron prevents cardiotoxicity caused by doxorubicin by maintaining mitochondrial function.Dabuzaron treatment increased ERK phosphorylation in a dose-dependent manner with an EC50 of 4.8 μM.

  • Metoprolol

    A selective β1 receptor blocker used in treatment of several diseases of the cardiovascular system, especially hypertension.